CPhI Conferences Launches Vaccines Summit 2012

Informations

• Publié par: cphi-conferences-india
• Nombre de lectures: 20
• Langue: English

Extrait

CPhI Conferences Launches Vaccines Summit 2012

PR Newswire MUMBAI, India, July 11, 2012

MUMBAI, India,July 11, 2012/PRNewswire/ -- 29-31 August,Hyderabad, India While the Indian pharmaceutical industry is expecting only a single digit growth rate in the near future, and is predicted to reachUS$975 billionby 2013, the outlook of the vaccine industry is one of continued growth. Between 2009and 2010, the global vaccine market grew almost 15% toUS$25.3 billion, and is predicted to reachUS$56.7 billionby 2017. In this regard, CPhI Conferences announces its inauguraltwo-day strategic Vaccines Summit 2012,taking place fromAugust 30-31inHyderabad, India. This conference focuses on the latest R&D advancements invaccines for tuberculosis vaccines, pneumococcal conjugate vaccines, HPV vaccines,combination vaccines,dengue vaccines, AIDS, malaria and thermostable vaccines and novel adjuvants.It also focuses on the vital concerns aroundvaccine manufacturing, scale up, QbD, cold chain management and technology transfer. The event includes an exclusiveseminar covering global regulations for vaccines, taking place on29 August 2012, which features the recent government initiatives, WHO prequalification for vaccines, regulatory framework forIndiaand best ways of overcoming regulatory complexities in the Emerging Markets (EMs) and Rest of the World (RoW) countries. This regulatory focused day is led by experts includingNirmal Kumar Ganguly, Distinguished Biotechnology Research Professor,Department of Biotechnology (Former Director General, Indian Council of Medical Research),Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Department of Biotechnology, Ministry of Science and Technology, Ajay Khera, Public Health Consultant and Deputy Commissioner, Child Health and Immunisation,Ministry of Health and Family Welfare,Madhur Gupta, Technical Officer (Pharmaceuticals),WHOIndia. Visit http://www.vaccines-summit.com/pr to view the complete programme. CPhI Conferences is a UBM brand. UBM (LSE: UBM) organises more than 300 events in 21 countries across industry sectors including food, pharma, energy, property, aviation, telecom and more. Our expertise is a proven guarantee of the quality of our events. UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughoutIndiaand in the publications of trade journals and magazines. For further details please visit the UBM India website, http://www.ubmindia.in. For further information please contact: Ms Asan Bano Customer Services Executive CPhI Conferences

[phone] [e-mail]